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Compartmentalized microfluidic platforms are an invaluable tool in
neuroscience research. However, harnessing the full potential of this
technology remains hindered by the lack of a simple fabrication approach for
the creation of intricate device architectures with high-aspect ratio features.
Here, a hybrid additive manufacturing approach is presented for the
fabrication of open-well compartmentalized neural devices that provides
larger freedom of device design, removes the need for manual
postprocessing, and allows an increase in the biocompatibility of the system.
Suitability of the method for multimaterial integration allows to tailor the
device architecture for the long-term maintenance of healthy human stem-cell
derived neurons and astrocytes, spanning at least 40 days. Leveraging
fast-prototyping capabilities at both micro and macroscale, a
proof-of-principle human in vitro model of the nigrostriatal pathway is
created. By presenting a route for novel materials and unique architectures in
microfluidic systems, the method provides new possibilities in biological
research beyond neuroscience applications.
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1. Introduction
The complexity of the human brain renders
it challenging to model the number of
simultaneous processes occurring in vivo
at any one time. However, culturing neu-
ronal populations in compartmentalized
microfluidic devices for neurite guidance
provides better means by which to de-
construct the spatiotemporal complexity
of normal development and establish-
ment of brain circuits in vitro.[1,2] Such
compartmentalized devices have become
a widely applied tool for the studying
of neuronal microenvironments.[3] They
typically consist of two main compo-
nents: microfluidic compartments for
the culture of physically separated neu-
ronal populations and microchannel
array connecting the compartments that
allows neurite outgrowth while preventing
cell migration. Since the first experiments with the Camp-
enot chamber were performed more than four decades ago,[4]
compartmentalized devices have been extensively used to
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Figure 1. Graphical representation of the 3D-printed soft lithography process: a) Design of the compartmentalized microfluidic device is created in a
graphic editing software. b) Standard photolithography is used to create a master mold with features for the replication of both microchannels and open
compartments. c) The device is made by direct 3D printing of PDMS on the master mold. d) Individual devices are peeled off the master mold, bound to
a cover glass, and cells are seeded and differentiated in the compartments. e) Healthy neurons are generated on the device and allowed to interconnect
through the microchannel arrays. The device design permits direct optical and physical access to the cells of interest.
study synaptic plasticity,[5] axonal injury and transport,[6] vi-
ral infection,[7] neural circuit formation,[8,9] as well as disease
processes.[10]
Microfluidic devices are most commonly fabricated using
soft lithography, a prototyping technique where a soft elastomer
poly(dimethylsiloxane) (PDMS) is replica-molded from a pho-
tolithographically patterned master mold. Gas permeability,
optical transparency, low cost, ease of handling, and biocompati-
bility are some of the advantages that have made PDMS the most
frequently used material in microfluidic cell biology research.[11]
However, even after decades of advancements in soft lithography,
PDMS microdevices and parts (e.g., for microcontact printing),
are still made by firstly pouring liquid elastomer over a carefully
micro or nanostructured mold and then, paradoxically, manually
cutting out individual pieces by hand using a sharp tool. This
step limits overall reproducibility, can damage microstructures,
and cause misalignment issues. Furthermore, it limits design
options. For instance, conventional soft lithography is inade-
quate for the realization of open compartment designs with high
aspect-ratio walls and well-defined microstructures. Indeed,
such designs have previously been sought, e.g., using hybrid
mold fabrication schemes and specialized equipment, with
varying degrees of success.[12,13]
In this paper we developed a novel additive manufacturing
technique for the fabrication ofmicrofluidic devices that provides
a simple, yet versatile, methodology which we term 3D-printed
soft lithography (Figure 1). The method retains the advantages
of the conventional soft lithography while it minimizes manual
postprocessing of the device, expands design possibilities, sim-
plifies the fabrication of high aspect ratio features, and allows re-
duction of the PDMS content through controlled deposition of
the elastomer. Furthermore, 3D-printed soft lithography allows
fast prototyping with precisely defined features across scales and
opens up possibilities for the introduction of new materials to
the soft lithography toolbox. The 3D-printed devices provide a
platform for long-term differentiation and maintenance of hu-
man stem-cell derived neurons and astrocytes as well as neurons
directly reprogrammed from adult human fibroblasts (or for that
matter, any cell cultures). To show the potential of the novel fabri-
cation approach, we undertook a proof-of-principle experiment in
which we modeled the nigrostriatal pathway using human neu-
ral stem cells. The degeneration of dopaminergic neurons in this
pathway is the hallmark of Parkinson’s disease (PD) and causes
the characteristic motor symptoms associated with it. An impor-
tant feature of the nigrostriatal pathway is the directionality of
dopaminergic projections from ventral midbrain to dorsal stria-
tum in the forebrain. By utilizing fast prototyping approach for
microstructure design, we engineered microchannels to maxi-
mize the unidirectional growth of dopaminergic projections be-
tween two compartments. The developed device does not only
provide a platform to study PD in vitro but also exhibits the ver-
satility of 3D-printed soft lithography in neuroscience.
2. Results
2.1. 3D-Printed Soft Lithography
PDMS is 3D-printed in two steps directly onto the silicon wafer
containing the master mold pattern by pressure driven extrusion
through a syringe nozzle (Figure 2a). Two inks were formulated
for this purpose: a flowing “gasket ink” for high fidelity molding
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Figure 2. Rheological properties of the inks: a) Illustration showing the deposition of the two inks on the master mold (not to scale). A flowing gasket
ink is printed directly on top of the master mold. The ink covers the small features for the molding of the microchannels but does not flow over the
tall features that mark the compartment borders creating defined vertical edges. Multiple layers of compartment ink are deposited on top of the gasket
to fabricate compartment walls. b) The complex viscosity at 0.01% strain increases as additives are mixed with the Sylgard 184 base. The finally used
gasket ink includes 15% fumed silica and 20% SE 1700. c) Decrease in viscosity with higher shear rates under steady-state conditions indicates shear
thinning behavior for both inks. d) Storage modulus (G′) and loss modulus (G′′) as a function of applied strain amplitude in an oscillatory sweep mode.
The compartment ink undergoes solid-to-liquid transition illustrated by the crossover around 1% strain. On the other hand, gasket ink is dominated by
liquid properties across the whole range of strain amplitudes.
without entrapment of air bubbles and a “compartment ink” for
the fabrication of vertical structures. Inks were created by blend-
ing two types of commercially available elastomers with very dif-
ferent rheological properties (Sylgard 184 and Dowsil SE 1700).
Sylgard 184 is a liquid elastomer widely used in conventional soft
lithography, whereas SE 1700 is a shear thinning PDMS elas-
tomer with well suited material properties for 3D printing ap-
plications, including open well structures.[14]
The gasket ink was created by modulating the rheology of Syl-
gard 184 as the base component. In plain form, this elastomer
behaves as a Newtonian fluid without sufficiently high viscos-
ity to be controllably extruded through a nozzle and to support
the weight of layers printed on top of it. The desired increase in
viscosity was achieved by the addition of fumed silica nanoparti-
cles and SE 1700 (Figure 2b). The nanoparticles, made of amor-
phous silicon dioxide, interact with each other through hydrogen
bonds and form a loose network that modifies the rheology of
the elastomer.[15] At the optimal formulation, the complex viscos-
ity of the ink at low strains is increased 100-fold (from 4 to 420 Pa)
compared to the pure Sylgard 184 elastomer. Unlike pure Sylgard
184, the gasket ink shows shear thinning behavior (Figure 2c), a
necessary feature for the controllable and consistent flow during
printing. Most importantly, the loss modulus of the gasket ink
at low strain rates is higher than the storage modulus indicating
that it has predominantly liquid-like properties at rest (Figure 2d).
This characteristic of the gasket ink allows it to flow after it is
deposited and uniformly cover the features on the master mold
(Figure 2a middle).
The compartment ink was formulated for the fabrication of
structurally stable high-aspect ratio vertical features. The base of
the compartment ink is SE 1700 elastomer which by itself is a
suitable material for 3D printing. Addition of Sylgard 184 to the
final formulation enhances the printing properties of the ink.[16]
The ink exhibits shear thinning behavior indicating its suitability
for extrusion-based 3D printing with high accuracy (Figure 2c).
Unlike the gasket ink, the compartment ink is dominated by
solid-like properties at rest with the elastic modulus being higher
than the loss modulus at low strains (Figure 2d). As a result, the
ink retains its shape once it is deposited maintaining the struc-
tural integrity of the compartment walls.
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Figure 3. Fabricating devices with complex designs: a) Image shows the silicon wafer containing the master mold for three device designs: “brain”
device, concentric circles device, and axotomy device. One device for each design is fully 3D-printed while the other molds are left empty in order to
visualize the starting point compared to the final product. b) Photographs of the fabricated device. Colored inks were poured into each compartment to
demonstrate physical separation between individual compartments. c) Inverted brightfield image of a compartment wall cross-section. The blue part of
the dimension line indicates the part of the wall printed with the gasket ink. The red part indicates the ribbed part of the wall printed with the compartment
ink. d) Brightfield image of the patterned wavy microchannels on the bottom face of the compartment wall. e) Middle: image composed of an inverted
brightfield image illustrating the edges of the gasket resembling a human head and a fluorescent image indicating the extent of the neuronal network in
each compartment marked by 𝛽-tubulin III, a microtubule element found almost exclusively in neurons; left: higher magnification fluorescent image of
the neurons in the middle of a compartment; right: higher magnification fluorescent image of the neurons extending projections throughmicrochannels.
To explore the fabrication capabilities of 3D-printed soft lithog-
raphy, we next generated several compartmentalized microflu-
idic devices with arbitrary complex designs: a “brain” device, a
concentric circle device, and an axotomy device (Figure 3a). The
fabrication of these devices is not possible with conventional
soft lithography and highlights the potential of 3D-printed soft
lithography for the manufacturing of multiscale features with
high-aspect ratio vertical compartment walls.
As a first example, we made a 4 × 4 cm compartmentalized
“brain” device with defined structural elements both at micro
and macroscale (printing of the device is shown in Video S1,
Supporting Information). The gasket of the device resembles the
outline of the human head while the five compartments for neu-
ronal cultures resemble five regions of the human brain. Com-
partments were loaded with inks of different colors in order to
demonstrate physical separation between them (Figure 3b). Each
compartment is enclosed within 5 mm tall walls allowing spa-
tial separation of cell bodies. The walls are vertical with width of
450 µm and height of 5 mm (Figure 3c). Such high aspect ratio
(11:1) was achieved by printing the compartment ink through a
200 µm nozzle with a single layer width. Individual layers can
be identified in the ribbed texture of the walls. As can be seen in
Adv. Sci. 2020, 2001150 2001150 (4 of 14) © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedsciencenews.com www.advancedscience.com
Figure 3d, microchannels are faithfully replicated from the mold
on the bottom face of the compartment walls. 4.7 µm high and
8 µm wide, the microchannels span the whole width of the wall
connecting the two adjacent compartments.
To indicate the biological suitability of the fabricated device
(Figure 3e middle), human neural stem cells (hNSCs) were dif-
ferentiated in the compartments generating a dense neuronal
network that covers the bottom surface of each compartment
(Figure 3e left). Microchannels then allow for neurite outgrowth
connecting different regions of the “brain” device (Figure 3e
right).
The second design that exemplifies the ability of the developed
method, the concentric circle device, is made to maximize the
microchannel interface between the compartments and incor-
porates a “return-to-sender” microchannel design that has been
shown to induce directionality in neurite outgrowth (Figure S1a–
c, Supporting Information).[17]
The third design, the axotomy device, exemplifies the suitabil-
ity of 3D-printed soft lithography for the fabrication of closed mi-
crofluidic channels. Besides the two open compartments, this de-
vice contains a closed microfluidic axonal compartment which
can be used for the severing of neural projections for the study
of axonal injury and regeneration (Figure S1d–f, Supporting
Information).
Due to the controlled deposition of PDMS, there is no need
for manual postprocessing (e.g., cutting with a scalpel or a biopsy
punch) of devices that can cause damage to the microstructures
or create unwanted overhangs (Figure S2, Supporting Informa-
tion). After the printing is done, fabricated devices are simply
cured in the oven, peeled off the master mold, and bound to a
cover glass. 3D-printed soft lithography could also be used for
more accurate and reproducible fabrication of stamps for micro-
contact printing where the positioning of the micropatterns with
respect to the outer boundaries of the stamp is a known issue
(Figure S3, Supporting Information).
2.2. Biocompatible Compartmentalized Devices for hNSC
Differentiation
Two different hNSC lines were used in this study. One was made
from the forebrain region of a human embryo and is hereafter
referred to as F-hNSC. The second was derived from the ventral
mesencephalon in the midbrain and is referred to as M-hNSC.
When differentiated in a conventional well plate, F-hNSCs
generate a cell population with a high percentage of astrocytes
while M-hNSCs generate a high percentage of dopaminergic
neurons.[18,19] Our initial experiments with conventional PDMS-
based microfluidic compartmentalized devices proved to have
detrimental effects on both cell lines (Figure 4a). At a certain
point during differentiation, cell death was observed as localized
necrotic kernel regions, which increased in size and eventually
spread throughout the whole cell population. F-hNSCs were
particularly sensitive to this phenomenon. As can be seen in
Figure 4a, this was evident as early as day 3 in vitro. Within
a couple of days necrosis expanded throughout the whole cell
population. As a result, it was not feasible to generate astrocytes
from F-hNSCs. We took advantage of the sensitivity of F-hNSCs
to the environmental perturbations as a robust readout to explore
the biocompatibility of the developed devices.
First, in order to decouple the effects of PDMS from the
influence of the microfluidic architecture, we differentiated
both F-hNSCs and M-hNSCs in XonaChips, a commercial
injection-molded two-compartment device made from cyclin
olefin copolymer with the same design as the conventional com-
partmentalized PDMS device.[20] In this device differentiation
was successful indicating compatibility of both cell lines with the
microfluidic environment (Figure S4, Supporting Information).
However, when we attempted to differentiate the F-hNSCs in
a commercial polystyrene 48-well plate using media that was
preconditioned in PDMS wells, the same pattern of necrosis, as
observed in a conventional PDMS device, occurred within the
first week of differentiation (Figure S5, Supporting Information).
These results indicate that it is the PDMS itself that affects the
cells and not the microfluidic environment.
One of the causes of the toxicity could be the presence of un-
cured PDMS oligomers that leach out of device walls and get
embedded into cell membranes.[21] It has been reported that ex-
tensive curing times and solvent extraction of unpolymerized
oligomers and metal catalysts used for curing the elastomer
enhance biocompatibility of the material.[22] In our case, sol-
vent extraction resulted in 4.6 ± 0.1% (n = 6) weight reduc-
tion in the conventional PDMS devices indicating clearing of a
large amount of unpolymerized oligomers. Matrix-assisted laser
desorption/ionization–time-of-flight (MALDI–TOF) analysis of
leached PDMS content showed the presence of PDMS oligomers
in the media of conventional devices when the curing time was
limited to 2 h while no oligomers were detected when curing
was extended to 24 h (Figure S6, Supporting Information). How-
ever, neither solvent extraction nor extensive curing resulted in a
drastic improvement in F-hNSC survival time during differentia-
tion suggesting that the residual presence of unpolymerized elas-
tomer could significantly affect cell viability. Furthermore, sol-
vent extraction is a long and laborious process that increases the
device fabrication time by more than a week and introduces the
risk of toxic effects from the unwashed solvent molecules.
Nonspecific absorption of proteins and small molecules is an-
other potential drawback of PDMS devices that could affect cell
differentiation and survival.[23] The porous nature of the elas-
tomer network allows the absorbed molecules to diffuse into the
bulk polymer.[24] As a result, the composition of the cell media
could be significantly altered. The absorption is time-dependent,
nonlinear, and variable between different compounds.[25] There-
fore, a simple change in the composition of cell culture media
would not solve the problem.
For both nonspecific absorption of molecules and leaching out
of uncured elastomer, the common limiting factor is the ratio be-
tween the total cell media volume to the total volume of PDMS
in a device. The amount of bulk polymer in the device acts as
a reservoir for the absorbed molecules and uncured oligomers
and influences the final equilibrium concentration established
between PDMS and cell media. The rate limiting factor that af-
fects the time before the equilibrium is reached is the surface
area of PDMS exposed to the cell media. The exposed surface
area dictates the rate at which both the oligomers leach out and
the molecules from the media are absorbed into the bulk of the
device.
Adv. Sci. 2020, 2001150 2001150 (5 of 14) © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedsciencenews.com www.advancedscience.com
Figure 4. Long-term culture of hNSCs in 3D-printed devices: a) Brightfield image of the necrotic core identified in the F-hNSC population 3 days after
the differentiation was initiated in a conventional compartmentalized PDMS device. On day 5 of differentiation, the necrotic region expands throughout
the whole population. b) Graphical illustration of a two-compartment device used in the cell viability study. c) Comparison of PDMS content between
the conventional device and the devices made using 3D printed soft lithography. d) A bar chart displaying the first recorded observation of the necrotic
region for each hNSC line in compartmentalized devices with decreasing ratios between the cell media and the PDMS surface area exposed to the media
(mean value with standard deviation). The insert shows live/dead staining of the cells after 40 days of differentiation in the device with PMMA extensions.
We hypothesized that a major reduction in the total amount
of PDMS in a device and the PDMS surface to media vol-
ume ratio would remove the toxic effect and allow culturing
and differentiation of hNSCs in the same conditions as in a
commercial polystyrene tissue culture well plate. We took ad-
vantage of 3D-printed soft lithography to make devices with
these specifications. To do so, we designed a rectangular de-
vice with two open compartments and 450 µm thin walls (Fig-
ure 4b). The device was either fully printed or, to further decrease
the amount of PDMS and show how the 3D-printing approach
could be combined with other materials, 0.5 mm high walls
were printed and then extended with micromilled poly(methyl
methacrylate) (PMMA) compartments or 3D-printed polylactic
acid (PLA) compartments. The conventional PDMS device, the
fully printed PDMS device, and the devices with PMMA or
PLA extension can be seen in Figure S7 in the Supporting
Information. After the fabrication, the devices were weighed (Fig-
ure 4c). Fully printed device reduces the total amount of PDMS
roughly 20 times compared to the conventional device while the
PMMA-extended device introduces a 60-fold reduction in PDMS
content. The ratio between the cell media volume and the PDMS
surface area exposed to cells was calculated to be 0.09, 1.5, and
15 for the conventional device, fully printed device, and PMMA-
extended device, respectively. This implies that there is a 170-fold
increase inmedia volume per surface area unit of exposed PDMS
for the PMMA-extended device compared to the conventional de-
vice, which should greatly minimize the effects of PDMS absorp-
tion and dilute any unpolymerized oligomers to levels below the
detrimental threshold. Indeed, as can be seen in Figure 4d, the
decrease of the total content and exposed surface area of PDMS
in the device had a remarkable effect on the hNSC survival dur-
ing the differentiation process. While fully 3D-printed devices
showed an improvement over the conventional microfluidic de-
vices (albeit not sufficient for long term cultures), when differ-
entiated in devices with PMMA extensions, neither cell lines
showed any signs of PDMS-specific necrosis even after 40 days
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in culture (Figure 4d inset). At this time point, the experiments
were stopped given a proof of principle of increased biocompati-
bility for these sensitive cell lines had been shown. In the process,
we also considered fully printed alternatives based on styrene–
isoprene–styrene (SIS) block copolymer inks (Figure S8, Sup-
porting Information). However, compared to PMMA/PDMS hy-
brid devises, these often detached from supports, and appeared
less biocompatible. Consequently, printed PDMS devices with
PMMA extensions were chosen for the subsequent experiments.
2.3. Generation of Functional Human Neurons and Astrocytes in
3D-Printed Devices
Immunocytochemistry showed that the hNSC differentiation in
the PMMA-extended devices was successful and not hindered by
environmental factors. Figure 5a shows high expression of neu-
ronal marker 𝛽-tubulin III in the cell population differentiated
from M-hNSCs while the same is not present in cells differenti-
ated from F-hNSCs. F-hNSC derived cells are on the other hand
rich in GFAP, an intermediate filament protein expressedmainly
in astrocytes. Additionally, tyrosine hydroxylase (TH), a rate lim-
iting enzyme in the synthesis of dopamine, is present in cells
derived from M-hNSCs while it is not present in those derived
from F-hNSCs. These results show the ability of our new system
to allow NSCs to differentiate into astrocyte rich cell populations
from F-hNSCs and to differentiate into dopaminergic neurons
from M-hNSCs, which is well in line with the previously pub-
lished results using conventional polystyrene tissue culture well
plates.[18,19] Additionally, to show that our devices are not compat-
ible only with human neural stem cell lines, we conducted direct
conversion to generate induced neurons (iNs) from adult human
patient derived fibroblasts [26] in the devices and managed to cul-
ture them for 30 days without detrimental effects (Figure S9, Sup-
porting Information).
To demonstrate the functional activity of the generated
neurons and astrocytes, we performed calcium imaging. Two
approaches were followed in order to differentiate neuronal and
astrocytic calcium activity. In the first approach, we expressed
GCaMP3, a genetically encoded calcium marker under the
MAP2 promoter, in order to visualize intracellular calcium
activity specifically in neurons. As can be seen in Figure 5b,
spontaneous calcium transients were recorded in the absence of
any depolarizing stimuli in the neuronal population generated
from M-hNSCs. This is a sign of a healthy cell population. The
transients indicate multiple spiking behavior for individual cells
with spike duration of 100–300 ms and an average interval of 1.1
± 0.4 s (Figure 5b left). Also, neuronal network generated from
M-hNSCs responds to the chemical stimulation (Video S2, Sup-
porting Information). In contrast, there was no calcium activity
observed in the astrocyte rich cell population generated from
F-hNSCs. To record activity within this population, we loaded
the cells with a membrane permeable fluorescent Ca2+ indicator
which is not cell type specific. This time, spontaneous calcium
activity was recorded in the astrocyte rich population (Figure 5c
left). Recorded Ca2+ peaked with an average delay of 0.96 ±
0.58 s following an exponential decay ranging from 5 s to more
than 15 s. The dynamics of the Ca2+ transients in the F-hNSC
population significantly differed from the recordings made in
the M-hNSC population and resembled the astrocytic footprint
of Ca2+ transients recorded in vivo. [27,28] These results demon-
strate that 3D-printed soft lithography can be used to make
microcompartment devices compatible with human stem cell
differentiation into healthy functional neurons and astrocytes.
2.4. Reconstructing Directionality in the Nigrostriatal Pathway
via Fast Prototyping of the Microscale Features
The nigrostriatal pathway is a dopaminergic pathway that con-
nects the Substantia nigra pars compacta (SNpc) in the midbrain
with the dorsal striatum in the forebrain (Figure 6a). This
dopaminergic connection is unidirectional with the dopaminer-
gic neurons projecting from the SNpc and delivering dopamine
to the dorsal striatum. It is the loss of the dopaminergic neurons
in the nigrostriatal pathway that is the hallmark of PD. Further-
more, there is mounting evidence suggesting that astrocytes
could play initiating pathogenic role in PD. It has been found
that PD-related genes are expressed in astrocytes and their
dysfunction could lead to neuronal toxicity.[29] These findings
indicate that astrocytes might be important in maintaining
functional activity of dopaminergic neurons in the nigrostriatal
pathway. To explore the capabilities of 3D-printed soft lithog-
raphy as a fast prototyping method by which to study neurite
growth through engineered microchannels, we constructed a
proof-of principle nigrostriatal pathway on-a-chip. We utilized
the two-compartment device from the previous section in order
to spatially separate dopaminergic neurons (representing mid-
brain) from astrocytes (representing forebrain) while facilitating
directional outgrowth of dopaminergic projections through en-
gineered microchannels. The architecture of the microchannels
was optimized to maximize the number and length of dopamin-
ergic axons protruding to the adjacent compartment while pre-
venting projections in the opposite direction, mimicking the in
vivo situation. Firstly, two lengths of microchannels were tested,
450 and 900 µm. As neural projections did not successfully
transverse the full length of the longer microchannels (Figure
S10, Supporting Information), we kept microchannel length
at 450 µm in subsequent experiments. Next, we explored how
the design of the microchannels affects the axonal outgrowth
generated from M-hNSCs. Although work in this field has been
reported in the literature, most of it was performed with primary
murine neurons.[8,17] Importantly, the growth dynamics and
developmental pathways underlying this process are different
for human dopaminergic neurons investigated here. Therefore,
in our study, we could not directly apply the designs reported for
murine cells. Instead, we screened 24 different microchannel de-
signs by varying the following parameters: microchannel height,
shape of the entrance into the microchannel, width of the middle
section of the microchannel, and the shape of the exit from the
microchannel (Figure 6a).We differentiated cells in one compart-
ment and observed growth of neural projections in the opposite
empty compartment. We identified six designs that showed the
effects of the microchannel dimensions on the outgrowth of M-
hNSC-derived neural projections (Figure 6b). 3.2 µm height hin-
dered the outgrowth regardless of the width of the channel with
only 12% of axons extending more than 500 µm into the adjacent
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Figure 5. Functional neurons and astrocytes in 3D-printed compartmentalized devices: a) Immunocytochemistry after 22 days of differentiation in a
3D-printed compartmentalized device with a PMMA wall extension. b) Differential fluorescence intensity profile as a function of time for M-hNSCs
expressing MAP2-GCamP3 (left); fluorescence image with segmented regions of interest corresponding to individual cells (middle); three timeframes
displaying the change in intercellular fluorescence intensity for two cells indicated by arrows (right). c) Differential fluorescence intensity profile as
a function of time for F-hNSCs loaded with Fluo3AM (left); fluorescence image with segmented regions of interest corresponding to individual cells
(middle); three timeframes displaying the change in intracellular fluorescence intensity for a single cell indicated by an arrow (right).
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Figure 6. Reconstruction of the nigrostriatal pathway on-a-chip: a) Graphical representation of the nigrostriatal pathway that unidirectionally connects
the dopaminergic neurons of the SNpc in themidbrain (M) to the dorsal striatum in the forebrain (F); graphical representation of the compartmentalized
device used in this section with the illustration of different microchannel designs. b) Graph showing the number of transmitted axons and their length in
the adjacent compartment for an array of 20 microchannels (n= 3) (top) and the corresponding fluorescent images of transmitted projections (bottom).
c) Fluorescent image showing directional growth of dopaminergic axons in the adjacent compartment innervating the opposite cell population. d)
Fluorescent images showing the transmitted dopaminergic axon in the opposite compartment surrounded by astrocytes. Synapsin is co-expressed with
TH on an axon transmitted in the adjacent compartment indicating the presence of synaptic vesicles. e) Brightfield image showing the micropipette tip
accessing a cell in the vicinity of the microchannels (left) Whole cell patch clamp recording, showing multiple induced action potentials (upper middle)
upon steps of current injection (lower middle). In Voltage clamp studies, cells displayed the presence of both Inward Sodium and Outward Potassium
currents (upper right) when steps of voltages where applied (lower right).
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compartment. Increasing the microchannel height to 4.7 µm but
keeping the width at 3 µm did not improve neurite outgrowth.
However, when the microchannel dimensions were raised to
a width of 6 µm and a height of 4.7 µm, we observed a 150%
increase in the number of transmitted axons with 75% extending
more than 500 µm into the adjacent compartment (Figure 6b).
Microchannels with larger dimensions did not effectively prevent
cell migration between the compartments. Finally, we explored
the effect of funnel design, also known as an axonal diode, on
axonal transmission.[30,31] 40 µm widening at the entrance to
the channel increases the probability of a neurite entering the
channel while a 3 µm constriction has the opposite effect (Fig-
ure 6a red and green triangle, respectively). The results indicate
that both the number of the growing axons and their length is
maximized when the wide opening is included in the design. The
axons protrude up to 2 mm into the adjacent compartment (Fig-
ure 6b green triangle). It is important to note that, in a separate
set of experiments, when the microchannel design was screened
for F-hNSCs (that do not project along the nigrostriatal pathway),
no projections were seen in the adjacent compartment from the
differentiated cells (Figure S11, Supporting Information).
After themicrochannel design had been optimized for the gen-
eration of an oriented neuronal network, we differentiated M-
hNSCs in the bottom compartment of a device and F-hNSCs in
the top compartment. Figure 6c displays the neuronal network
generated in the device after 20 days of differentiation. The bot-
tom compartment is rich in dopaminergic neurons with pro-
jections that extend through the microchannels and innervate
the adjacent cell population. Dopaminergic projections extend
deep into the opposite compartment, up to 2 mm, as expected
with the chosen microchannel design. Synapsin is expressed in
the dopaminergic projections indicating the presence of synaptic
vesicles in the adjacent compartment, a key component for func-
tional neuronal connections between the compartments (Fig-
ure 6d). In the same figure, a network of astrocytes can be ob-
served surrounding the transmitted dopaminergic projection.
Besides optical access for microscopy, thin vertical walls of
the developed device enable direct physical access to the cells
in the vicinity of the microchannels, allowing electrophysiolog-
ical whole cell-patch clamp investigation of the differentiated
hNSCs in the engineered nigrostriatal pathway (Figure 6e left).
With the use of microelectrodes for single-cell electrophysiologi-
cal recordings we targeted neuronal-like cells in the cultures. By
monitoring the passivemembrane properties, we found that cells
retained a resting membrane potential ranging from −30 to –
45 mV, indicating that the cells are successfully differentiating
towards the relevant neuronal phenotype. The membrane resis-
tance, a value dependent on the density of ion channels in the
membrane, was similar among all the patched cells. Also, the size
of the cells, indicated by the membrane capacitance, was similar
among the patched cells. In the current clamp mode, steps of
currents were injected in the cells in order to detect their abil-
ity to generate action potentials (AP) (Figure 6e middle). All the
recorded cells showed the presence of induced APs as reported
before for these cells in commercial tissue culture dishes.[32]
These recordings indicate the ability of the cells to communicate
and generate electrical signals resulting from membrane depo-
larization. In the voltage clamp mode, we checked the presence
of inward sodium and outward potassium currents as a measure
of the expression of voltage-gated sodium and potassium chan-
nels (Figure 6e right). All the cells showed such currents in the
membrane. This data confirms that the cells are electrophysio-
logically active highlighting the potential of the developed device
for modeling and studying neuronal communication.
3. Discussion
The hybrid additive fabrication approach presented in this paper
overcomes several limitations associated with the conventional
soft lithography systems based on bulk PDMS casting. In partic-
ular, it removes the need formanual cutting of the compartments
using, e.g., blunt needles or biopsy punches, which is laborious
and may lead to damage or misalignment of microstructures.
Further, our procedure allows for a much broader range of device
designs, such as high-aspect ratio open-compartment microflu-
idic systems. A few recent reports have presented alternative
methods aimed at overcoming the limitations associated with
such conventional devices. For instance, one report combined
cast PDMS with computer numerical control (CNC) milling and
hot embossing to create desired features in a PMMA master
mold [12] while another extended the features on the master
SU-8 mold using 3D-printed steel inserts.[13] Compared to these
procedures, the 3D-printed soft lithography route presented here
introduces a simple yet versatile and reproducible process flow.
It simultaneously remains fully compatible with master molds
that are used in conventional soft lithography and which are
fabricated with standardized cleanroom processes for SU-8 pho-
tolithography. Additionally, 3D-printed soft lithography provides
a route for the use of other materials, not compatible with bulk
casting, for molding of microfluidic device. Stereolithography,
another increasingly popular fabrication approach, has been
used to produce high aspect ratio microfluidic devices but its
resolution is currently limited to 18 µm formicrofluidic channels
and as such could not be utilized for neuroscience applications
to create microchannels needed for neurite guidance with design
variations on the order of a single micrometer.[33]
Besides the expansion of design capabilities, our procedure al-
lows many attractive material properties of PDMS to be exploited
while removing possible drawbacks related to biological applica-
tions by limiting the total amount of PDMS in a functional device.
Leveraging this advantage, we were able to create compartmen-
talized devices for long-term culture of human stem cell-derived
neurons and astrocytes. Notably, both cellular phenotype and vi-
ability was fully sustained for at least 40 days. This demonstrates
that, while PDMS in excessive amounts may cause harm to del-
icate cell cultures, we can mitigate these to the point of allow-
ing long-term culture and studies on highly sensitive hNSCs.
This accomplishment is important because the long term cul-
tures (up to at least two weeks) of human stem-cell derived neu-
rons have been demonstrated so far only in several reports while
the large volume of work has been performed on the primary
murine neurons that are more robust and require shorter culture
times.[34,35,36] Notably, our findings also indicate that elastomers
such styrene–isoprene–styrene block copolymer inks, which are
less used for in vitro biology, but could be considered as alterna-
tives to PDMS in our procedure, are not unproblematic. As alter-
native to lithography-based devices, commercially available injec-
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tionmolded devices could be an appropriate solution for sensitive
neuronal cultures.[20] However, such devices are costly in small
quantities and do not offer design freedom and rapid prototyping
capabilities that 3D-printed soft lithography has to offer.
Finally, we demonstrated the versatility of our procedure by
creating a proof-of-concept culture system which allowed us to
reconstruct the nigrostriatal pathway in the device. This was
done by screening for microchannel designs that maximized
the growth of dopaminergic projections from hNSC-derived
midbrain neurons. The results indicate how important fast
prototyping and design flexibility are when creating devices
for explorative studies with human cells. Alterations of the mi-
crochannel shape and dimensions in the micrometer range had
a significant impact on the outgrowth of the projections, indicat-
ing further the importance of preserving intact microstructures
during the fabrication process. The developed system demon-
strates that 3D-printed soft lithography allows design flexibility
covering the single micrometer to centimeter range allowing
adaptation of the device to specific purpose and specific cell type.
We demonstrated only one scenario in which the role of astro-
cytes in the protection of dopaminergic neurons can be studied.
Possible alternatives could be replacing astrocytes with GABAer-
gic neurons which are inhibited by the activity of dopaminergic
neurons in vivo, to study signal propagation. A system could also
be designed to study transmission of 𝛼-synuclein aggregates, a
well-known pathology of PD. In a bigger picture, together with
stem cell technology, direct reprogramming protocols, and gene
editing tools, our approach opens up a host of opportunities
in neuroscience to study neurological diseases, neural network
formation, and test drugs in vitro.
4. Conclusion
In summary, we demonstrated an additive manufacturing ap-
proach to soft lithography that allows simple fabrication of the
open-well compartmentalized devices with vertical walls and con-
trol over both microscale and macroscale features. Compared to
the conventional soft lithography, our approach expands the de-
sign possibilities, overcomes the issue of inaccuracy and damage
caused by manual postprocessing, and allows an increase in the
biocompatibility of the system. Leveraging the advantages of the
developed approach, we created compartmentalized devices that
support differentiation of sensitive hNSCs into healthy neurons
and astrocytes and their long-term maintenance. Furthermore,
we engineered an in vitro proof-of-conceptmodel of the nigrostri-
atal pathway. Our approach relies on affordable commercial ma-
terials, conventional photolithography protocols, and 3D printing
technology that is an increasingly common part ofmany research
institutes. Due to its simplicity, versatility, and accessibility, 3D-
printed soft lithography has a potential to become a frequently
used solution for the fabrication of microfluidic devices.
5. Experimental Section
Device Design and Master Mold Fabrication: Device elements were de-
signed in Adobe Illustrator and further processed in Tanner L-Edit soft-
ware. Silicon wafers with thermally grown silicon oxide were used as sub-
strates for master fabrication. As a first layer, the pattern for the molding
of microchannels was fabricated using SU-8 photolithography (for 4.7 µm
tall microchannels) or reactive ion etching (for 3.2 µm tall microchannels).
A second 180 µm high layer for themolding of the compartments was then
fabricated using SU-8 photolithography.
Patterning 4.7 µm Tall MicrochannelMold—SU-8 2005 was spin coated
at 5000 rpm for 60 s on a RCD8 T spin coater (Süss MicroTec) to obtain
a 4.7 µm thick layer. The wafers were then soft baked for 3 min at 90 °C
on a hot plate. The pattern for the microchannels was exposed using a
maskless aligner (MLA100, Heidelberg Instruments). Post exposure bake
was then performed for 3 min at 90 °C. This was followed by development
in a dedicated bath containing the developer mr-Dev 600 for 10 min. The
wafers were thoroughly rinsed using isopropanol.
Patterning 3.2 µm Tall Microchannel Mold—A 1.5 µm negative resist
(nLOF 2020) was spin coated and baked at 110 °C to act as an etch
mask. The microchannel pattern was exposed using a maskless aligner.
The wafers were baked post exposure at 110 °C and developed. A hard
bake at 110 °C followed development to allow for the evaporation of any
solvent and harden the resist for dry etching. The silicon oxide layer was
first completely etched in advanced oxide etcher (STSMESCMultiplex ICP)
using fluorine chemistry. This was followed by 1 min silicon etch to define
the depth of the microchannel pattern at 3.2 µm. The resist mask was then
stripped in oxygen.
Patterning 180 µmTall CompartmentMold—A 180 µm thick resist layer
of SU-8 2075 was spin coated followed by a soft bake at 50 °C for 6 h.
The compartment pattern was then exposed using a maskless aligner. The
post exposure bake was performed at 50 °C for 6 h to allow crosslinking
of the exposed SU-8 structures. The wafers were then developed as before
for 20 min and thoroughly rinsed in isopropanol. Finally, a hard bake was
performed at 90 °C for 15 h.
The masters were then subjected to surface modification using
1H,1H,2H,2H-perflourodecyltrichlorosilane (FDTS) to facilitate the re-
moval of cured PDMS from the mold. The height of the structures and
their fidelity was verified using a stylus profilometer and an optical micro-
scope. Finally, the wafers were diced for better fitting and alignment on the
printing stage.
Ink Formulation, 3D Printing, and Device Assembly: To create the stock
for the gasket ink, fumed silica nanoparticles (200–300 nm average par-
ticle size, Sigma-Aldrich) were gradually added to the Sylgard 184 elas-
tomer (Dow Corning) until a 15% fumed silica content was reached. ≈1 g
of nanoparticles was added to the elastomer at a time andmixed for 1 min
at 2500 rpm in a dual rotation mixer (SpeedMixer, Hauschild). This was
repeated until a desired concentration was reached. The mixture was left
to rest overnight and mixed again in order to reach a homogenous texture
that was kept as a stock for the following steps. To create the gasket ink,
Sylgard 184 with 15% fumed silica was supplemented with 20% Dowsil
SE 1700 (Dow Corning). To create the compartment ink, Dowsil SE 1700
was supplemented with 10% Sylgard 184. Corresponding crosslinkers for
the elastomers were added in 10:1 ratio. The inks were mixed for 30 s at
2700 rpm in a dual rotation mixer and loaded in a 5 cc syringe barrels. In
order to remove the bubbles, syringes were centrifuged for 3 min at 1700
G. Syringes were then capped with plastic conical needles (200 µm inner
diameter) and loaded onto the 3DDiscovery bioprinter (regenHU). Silicon
wafers containing themastermold were immobilized on the printing stage
using vacuum suction. Printing path, based on the design created for the
master fabrication, was defined in BioCad software (regenHU). Printing
was done at room temperature directly on the silicon wafer via pneumatic
extrusion with the gasket ink extruded at 550 Pa and the compartment ink
at 275 Pa air pressure. Nozzle speed for both inks was set at 10 mm s−1.
Gasket ink was printed at a 150 µm layer height while the compartment ink
was printed at a 190 µm layer height. For the devices with PMMA or PLA
extensions, only three layers of compartment ink were printed in order to
allow a flat surface to be present for the attachment of fibers. Following
the printing, the silicon wafer containing the printed devices was placed
in the oven at 60 °C for 2 days in order to fully cure silicon elastomers.
PLA extensions were printed on a Felix Pro 3 3D printer (Felix Robotics)
using a transparent PLA filament. PMMA extensions were micromilled
in a 5 mm thick PMMA sheet using a 1.5 mm endmill. Extensions were
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attached to the base by applying a thin layer of PDMS elastomer and cur-
ing the device overnight at 60 °C. Once the curing was over, individual de-
vices were peeled off the silicon wafer and sterilized in 96% ethanol. Each
device was bound covalently to a glass coverslip by exposure to air plasma.
As a final step before the cells were seeded, compartments were incubated
at 37 °C overnight with 1:100 dilution of Geltrex (ThermoFisher Scientific)
in phosphate-buffered saline (PBS) in order to facilitate cell adhesion to
the glass surface. Videos and photographs of the printing process and the
final devices were taken using a D7200 camera (Nikon). Brightfield im-
ages of the wall cross-section and microchannel designs were taken on a
Primovert inverted widefield microscope (Zeiss).
Rheology: Characterization of the rheological properties of the inks
was performed on a Discovery HR-2 rheometer (TA Instruments)
equipped with a 25mmparallel-plate geometry. Measurements were taken
at 25 °C on freshly mixed inks. Oscillatory amplitude sweeps at 1 Hz were
performed for the values of strains ranging from 0.01% to 100%. Same
amplitude sweeps were used to obtain complex viscosity values at 0.01%
strain. Steady-state flow curves were acquired at shear rates varying be-
tween 0.01 and 100 s−1.
MALDI–TOF Oligomer Detection: 15 conventional devices were pre-
pared per condition (2 h curing time and 24 h curing time). Each microflu-
idic channel in a device was filled with 10 µL of ultrapure water and in-
cubated for 72 h at 37 °C. The contents of all the channels were pooled
together, lyophilized, and resuspended in toluene. Dithranol matrix, sam-
ple, and silver trifluoroacetate weremixed in 10:5:1 ratio and analyzed on a
MALDI–TOF mass spectrometer (Autoflex Speed, Bruker). 0.02 mg mL−1
10 cs PDMS in toluene was used as a reference sample.
hNSC Culture and Differentiation: Both hNSC lines used in this study
were cultured identically as described before.[19] The hNSCs were cul-
tured for at least two passages after thawing before being seeded onto the
coatedmulticompartment devices. Cells were seeded in the samemedium
that was used before for their maintenance, termed growth medium.
The basis of this growth medium is DMEM/F12 (ThermoFisher Scien-
tific) with GlutaMAX (ThermoFisher Scientific). Additionally, the medium
contained 6 g L−1 glucose (Sigma Aldrich), 5 × 10−3 m HEPES (Ther-
moFisher Scientific), 0.5 % w/v AlbuMAX (ThermoFisher Scientific), 40
× 10−6 m each of l-alanine (MerckMillipore), l-asparagine monohydrate
(MerckMillipore), l-aspartic acid (MerckMillipore), l-glutamin acid (Mer-
ckMillipore), and l-proline (MerckMillipore), 100× diluted N-2 supple-
ment (ThermoFisher Scientific), penicillin/streptomycin mix, 20 ng L−1
each of epidermal growth factor (EGF) and fibroblasts growth factor (FGF)
(R&D systems).
24 h after seeding, the growth medium was replaced with differentia-
tion medium. Differentiation medium was prepared using the same com-
ponents as growth media, but with the EGF and FGF being substituted
by 1 × 10−3 m dibutyryladenosine 3′,5′-cylic monophosphate sodium salt
(Sigma Aldrich) and 2 ng L−1 GDNF (PeproTech). After 48 h, the differenti-
ation medium was completely replaced with fresh differentiation medium.
Then, 2/3 differentiation medium was replaced with fresh differentiation
medium every second day until the end of the experiment.
Generation of Induced Neurons from Fibroblasts: Adult dermal fibrob-
lasts were obtained from the Parkinson’s Disease Research clinic at the
John van Geest Centre for Brain Repair (Cambridge, UK) with informed
consent from the patients and used under local ethical approval (REC
09/H0311/88). For biopsy sampling information see Drouin-Ouellet et al.
2017.[26] Fibroblasts expansion and cultures see Birtele et al. 2019.[37] The
cell lines used in this study came from two healthy 67- and 70-year old fe-
males at the time of skin sampling.
The reprogramming protocol used DNA plasmids expressing the open
reading frames (ORFs) for Ascl1, Brn2 with miRNA loops for miR-9/9*
andmiR-124 in combinationwith shRNA targeting REST. Used lentiviruses
were third generation vectors containing a nonregulated ubiquitous phos-
phoglycerate kinase (PGK) promoter. The vectors were used at final MOI
20. All viruses used in this study tittered between 3 × 108 and 6 × 109 pfu
mL−1.
Prior to plating, the wells were coated overnight with a combination
of polyornithine (15 µg mL−1), fibronectin (0.5 ng µL−1), and laminin
(5 µg mL−1) (PFL). Fibroblasts were plated at a density of 27 800 cells
cm−2. Three days after the viral transduction, the fibroblast medium was
replaced with neural differentiation medium (NDiff227, Takara-Clontech)
supplemented with growth factors at the following concentrations: LM-
22A4 (2 × 10−6 m, R&D Systems), GDNF (2 ngmL−1, R&D Systems), NT3
(10 ng µL−1, R&D Systems), as well as db-cAMP (0.5 × 10−3 m, Sigma)
and the small molecules CHIR99021 (2 × 10−6 m, Axon), SB-431542 (10 ×
10−6 m, Axon), noggin (0.5 µg mL−1, R&D Systems), LDN-193189 (0.5 ×
10−6 m, Axon), valproic acid sodium salt (VPA, 1 × 10−3 m , Merck Milli-
pore). Half medium changes were performed every two days for the first 30
days of conversion, whereas in the later stages of conversion the medium
changes were done every three days. At 18 days post-transduction, the
small molecules were withheld, and the neuronal medium was supple-
mented only with LM-22A4, GDNF, NT3, and db-cAMP until the end of
the experiment.
Whole Cell Patch-Clamp Recording: Cells were moved to a recording
chamber and submerged in a flowing artificial cerebrospinal fluid (ACSF)
solution gassed with 95% O2 and 5% CO2 at 23 °C according to stan-
dard procedures for recording. The composition of the ACSF was: 126
×10−3 mNaCl, 2.5×10−3 m KCl, 1.2×10−3 mNaH2PO4-H2O, 1.3×10−3 m
MgCl2-6H2O, 2.4 ×10−3 m CaCl2-6H2O, 22 ×10−3 m NaHCO3, 10 ×10−3
m glucose. The pH of the solution was adjusted to 7.4. Multi-clamp 700B
(Molecular Devices) was used for recordings and signals were acquired
at 10 kHz using pClamp10 software and a data acquisition unit (Digidata
1440A, Molecular Devices). Input resistances and injected currents were
monitored throughout the experiments. Borosilicate glass pipettes (4–7
MΩ) for patching were filled with the following intracellular solution: 122.5
×10−3 m potassium gluconate, 12.5 ×10−3 m KCl, 0.2 ×10−3 m EGTA, 10
×10−3 mHEPES, 2×10−3 mMgATP, 0.3×10−3 mNa3GTP, and 8mvNaCl.
Solution was adjusted to pH 7.3 with KOH. Resting membrane poten-
tials were monitored immediately after breaking-in in the current-clamp
mode. Membrane capacitance was monitored throughout the recordings
and recordings where discarded if changes in values higher than 30%were
observed. The membrane potential was kept between −60 to −70 mV and
currents were injected from −20 to +90 pA with 10 pA increments to
induce AP. Inward sodium and delayed rectifying potassium currents
were measured in the voltage clamp mode at depolarizing steps of
10 mV.
Calcium Imaging—GCamP3: The MAP2-GCamP3 lentiviral reporter
plasmid (Addgene Plasmid 43917) was packaged in HEK-293T cells us-
ing pM2.G and PMDLg. Lentivirus titers between 3 × 108 and 6 × 109 pfu
mL−1 were used for these experiments. Virus was added to the media at
day 18 of culture at MOI 5 to ensure detectable fluorescent levels. After 24
h incubation, a total media change was performed and fluorescent neu-
rons for analysis appeared 24–48 h after transduction.
Calcium Imaging—Fluo3 AM: Cells were incubated for 30 min at 37 °C
with 3 × 10−6 m Fluo3 AM calcium indicator (ThermoFisher Scientific)
in cell culture medium containing 0.02% Pluronic F-127 (Sigma Aldrich).
Cells were then rinsed in cell culture media and incubated for 30 min at
37 °C before imaging.
Calcium imaging of neurons containing the MAP2-GCamP3 reporter
and the cells loaded with Fluo3AM was performed in the same way, as
follows. Cell culture media was replaced with 100 µL baseline buffer con-
taining 1.2 × 10−3 m MgCl2, 2 × 10−3 m CaCl2, 150 × 10−3 m NaCl, 5 ×
10−3 m KCl, 5 × 10−3 m glucose, and 10 × 10−3 m HEPES. Imaging was
performed on an inverted Ti2 microscope (Nikon) equipped with a CSU-
W1 spinning disc system (Yokogawa), a sCMOS camera (Teledyne Pho-
tometrics), and a 20× objective. Environment control chamber was used
to maintain the temperature at 37 °C and CO2 level at 5% during imag-
ing. Exposure time was set to 30 and 100 ms depending on the dynamics
of calcium transients. Firstly, spontaneous activity was recorded. Finally,
stimulated calcium influx was recorded by inducing cell membrane depo-
larization through the injection of 50 µL of stimulation buffer containing
1.2 × 10−3 m MgCl2, 2 × 10−3 m CaCl2, 5 × 10−3 m NaCl, 450 × 10−3 m
KCl, 5 × 10−3 m glucose, and 10 × 10−3 m HEPES buffer. Images were
analyzed in ImageJ (NIH) and plotted in QtiPlot.
Immunocytochemistry and Live/Dead Staining: At the experimen-
tal endpoint, cells were fixed with 4% paraformaldehyde and stained
using standard protocols and the following antibodies: 𝛽-tubulin III
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(mouse, Sigma Aldrich T8660, 1:1000), TH (rabbit, PelFreez Biologi-
cals P40101, 1:1000), GFAP (rabbit, Dako Z0334, 1:1000; mouse, Bi-
olegendSM121, 1:500), synapsin (rabbit, Invitrogen 72732524, 1:2000).
For fluorescent stainings, Alexa 546 (goat anti-mouse, Thermofisher Sci-
entific A-11030, 1:500), Alexa 647 (goat anti-rabbit, ThermoFisher Sci-
entific A-21245, 1:500), Cy5 (donkey anti-rabbit, Jackson Immunore-
search, 711605152, 1:500). Nuclei were counterstained using DAPI (4′,6-
diamidino-2-phenylindole) (1:1000) or 2 µg mL−1 Hoechst 33342.
Live and dead staining was done by incubating cells for 30 min at 37 °C
in 2 × 10−6 m Calcein AM (Sigma Aldrich) and 2 × 10−6 m Ethidium
homodimer-1 (EthD-1, ThermoFisher).
Themiddle image in Figure 2d was acquired via a 5× 5 cm tile scan with
online image stitching on the above mentioned Ti2 microscope using an
objective with 4× magnification. The rest of the images were acquired on
an LSM 710 (Carl Zeiss) inverted confocal microscope. Objectives with
10×, 20×, and 60× magnification were used. Images were processed and
analyzed in ImageJ software.
Scanning Electron Microscopy: Samples were mounted on 25 mm alu-
minum stubs, sputter coated with 10 nm platinum/palladium (80:20) and
imaged in a Jeol JSM-7800F scanning electron microscope.
Statistical Analysis: Microsoft Excel and QtiPlot were used for the sta-
tistical analysis of the data presented in this work. The pre-processing and
data presentation were done in the following way. Figure 1c,d showsmean
± SD. Data in Figure 5b,c is represented as time series of total fluores-
cence intensity from selected regions of interest differential to the initial
value. Data in Figure 6b shows the total number of neurites counted in the
compartment adjacent to the compartment with cell bodies. Color coding
indicates the length of the neurite binned in six categories. The data in
Figure S3c in the Supporting Information underwent zero mean normal-
ization and is presented as mean ± SD with individual data points also
displayed. Figure S3d in the Supporting Information shows mean ± SD
with individual data points displayed as well. Sample sizes are noted in
the corresponding figures.
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